Breaking News Bar

Business News and Information

Aparna's Story: Redefining Possibilities for Patients with Rare Diseases

SOURCE: Bristol-Myers Squibb Company


Aparna had only been working as a clinical programmer on Bristol-Myers Squibb’s Global Biometrics Sciences team for six months when five-year-old Tayjus was diagnosed with Duchenne Muscular Dystrophy (DMD). Universal support from managers, co-workers, friends and family has helped her redefine what can be achieved by focusing on one day, and one goal, at a time. Now, 14 years later, Aparna and Tayjus are supporting Bristol-Myers Squibb’s advocacy and clinical development teams—helping them understand the challenges of dealing with rare childhood diseases so they can design more accommodating clinical trials with better access for patients and caregivers. 


Join Bristol-Myers Squibb Online:





Tweet me: Meet Aparna: Redefining possibilities for patients with rare diseases at Bristol-Myers Squibb

KEYWORDS: Health, Ethical Production and Consumption, Bristol-Myers Squibb, Corporate Social Responsibility, diseases, Duchenne Muscular Dystrophy, worldwide, Science, patients, Advocacy, clinical trials


Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear